Pew Supports FDA Guidance Regarding Dietary Supplements

Pew Supports FDA Guidance Regarding Dietary Supplements

The Pew Charitable Trusts submitted comments this month supporting draft guidance that the Food and Drug Administration issued in August on the new dietary ingredients (NDI) notification process for supplement manufacturers and distributors. NDIs are vitamins, minerals, or herbs that were not on the market before Oct. 15, 1994. Manufacturers are required in most cases to notify FDA before marketing a product that contains an NDI to show that the substance is “reasonably expected to be safe.”

Unlike drugs, which must go through testing for safety and effectiveness before being made available to patients, dietary supplements typically do not require premarket review or approval by FDA, making the NDI process an important protection for consumers. FDA’s draft guidance includes when the supplement industry should submit an NDI notification, what to include, and how to conduct appropriate safety assessments.

The guidance also attempts to provide clearer direction on manufacturing processes and chemical alterations that significantly change the source material, essentially creating an NDI that may or may not be safe. For example, manufacturing changes that alter the chemical or molecular composition or structure of a dietary ingredient could affect how it behaves when ingested, potentially rendering it toxic. This guidance will help ensure that if an ingredient is extensively altered, manufacturers and FDA have the evidence to conclude that the new ingredient is reasonably expected to be safe.

Composite image of modern city network communication concept

Learn the Basics of Broadband from Our Limited Series

Sign up for our four-week email course on Broadband Basics

Quick View

How does broadband internet reach our homes, phones, and tablets? What kind of infrastructure connects us all together? What are the major barriers to broadband access for American communities?

Pills illustration
Pills illustration

What Is Antibiotic Resistance—and How Can We Fight It?

Sign up for our four-week email series The Race Against Resistance.

Quick View

Antibiotic-resistant bacteria, also known as “superbugs,” are a major threat to modern medicine. But how does resistance work, and what can we do to slow the spread? Read personal stories, expert accounts, and more for the answers to those questions in our four-week email series: Slowing Superbugs.